Page last updated: 2024-10-18

dihydroxyphenylalanine and Glioma

dihydroxyphenylalanine has been researched along with Glioma in 58 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"The aims of the present study were to: 1- critically assess the utility of L-3,4- dihydroxy-6-18Ffluoro-phenyl-alanine (18F-DOPA) and O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) Positron Emission Tomography (PET)/Computed Tomography (CT) in patients with high grade glioma (HGG) and 2- describe the results of 18F-DOPA and 18F-FET PET/CT in a case series of patients with recurrent HGG."5.01Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience. ( Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V, 2019)
"We report the finding of increased F-3,4-dihydroxyphenylalanine uptake of the brain parenchyma adjacent to developmental venous anomalies, incidentally discovered in 3 pediatric patients with diffusely infiltrating gliomas."3.8318F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors. ( Cabria, M; Garrè, ML; Morana, G; Piccardo, A; Rossi, A, 2016)
"To compare MRI using perfusion and diffusion techniques with 6-[(18)F]-fluoro-L-3,4-dihydroxyphenylalanine ((18)F-FDOPA) positron emission tomography (PET) in the follow-up of low-grade gliomas (LGGs) and to identify the best imaging parameter to differentiate patients with different prognosis."3.83Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET. ( Bozzao, A; Cicone, F; Mancuso, V; Minniti, G; Napolitano, A; Romano, A; Rossi Espagnet, MC; Scaringi, C, 2016)
"To compare the diagnostic information obtained with 6-[(18)F]-fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET and relative cerebral blood volume (rCBV) maps in recurrent or progressive glioma."3.81Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI. ( Bozzao, A; Cicone, F; Filss, CP; Galldiks, N; Langen, KJ; Minniti, G; Papa, A; Rossi-Espagnet, C; Scaringi, C; Scopinaro, F; Shah, NJ, 2015)
"We report the finding of late persistent increased putaminal F-3,4-dihydroxyphenylalanine (DOPA) uptake following resection of a high-grade glioma involving the lateral portion of the ipsilateral precentral gyrus."3.81Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity? ( Garrè, ML; Morana, G; Nobili, F; Piccardo, A; Rossi, A, 2015)
"For recurrent malignant glioma treated with bevacizumab and irinotecan, FLT kinetic parameters obtained early after the start of treatment (absolute values and their associated changes) can provide sufficient information to predict OS with reasonable confidence using MLR."3.80¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors. ( Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M, 2014)
"Nineteen patients with newly diagnosed high-grade gliomas underwent computed tomography (CT), gadolinium contrast-enhanced MRI, and (18)F-FDOPA PET/CT."3.79High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. ( Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S, 2013)
"Tc-GH SPECT/CT was positive for recurrence in 22 and negative in 8 patients."2.79Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study. ( Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Kumar, A; Malhotra, A; Sharma, P; Singla, S, 2014)
"Differentiation between recurrence and radiation necrosis in patients with glioma is crucial, since the two entities have completely different management and prognosis."2.7818F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. ( Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P, 2013)
"In cancer patients with hypersplenism-related thrombocytopenia, PSAE is a safe intervention that effects a durable elevation in platelet counts across a range of malignancies and following the re-initiation of chemotherapy."2.73 ( Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I, 2007)
"Recurrent glioma was confirmed by surgical biopsy."1.38Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT. ( Calabria, F; Schillaci, O, 2012)

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19903 (5.17)18.7374
1990's1 (1.72)18.2507
2000's7 (12.07)29.6817
2010's33 (56.90)24.3611
2020's14 (24.14)2.80

Authors

AuthorsStudies
Langen, KJ2
Mottaghy, FM1
Bertaux, M2
Berenbaum, A1
Di Stefano, AL1
Rozenblum, L2
Soret, M2
Bergeret, S1
Hoang-Xuan, K1
Tainturier, LE1
Sgard, B1
Habert, MO1
Delattre, JY1
Dehais, C1
Idbaih, A1
Pyatigorskaya, N1
Kas, A3
Zaragori, T3
Verger, A6
Fiz, F1
Bini, F1
Gabriele, E1
Bottoni, G1
Garrè, ML5
Marinozzi, F1
Milanaccio, C2
Verrico, A1
Massollo, M3
Bosio, V1
Lattuada, M1
Rossi, A5
Ramaglia, A1
Puntoni, M3
Morana, G5
Piccardo, A5
Breen, WG1
Youland, RS4
Giri, S1
Jacobson, SB1
Pafundi, DH4
Brown, PD1
Hunt, CH2
Mahajan, A1
Ruff, MW1
Kizilbash, SH1
Uhm, JH1
Routman, DM1
Jones, JE1
Brinkmann, DH4
Laack, NN4
Jiang, S1
Li, X3
Zhang, F1
Mao, J1
Cao, M1
Zhang, X1
Huang, S1
Duan, X1
Shen, J1
Darcourt, J2
Chardin, D1
Bourg, V1
Gal, J1
Schiappa, R1
Blonski, M2
Koulibaly, PM1
Almairac, F2
Mondot, L1
Le Jeune, F1
Collombier, L1
Taillandier, L2
Todeschi, J1
Bund, C2
Cebula, H1
Chibbaro, S1
Lhermitte, B2
Pin, Y1
Lefebvre, F2
Namer, IJ2
Proust, F2
Guedj, E3
Bielle, F1
Ollivier, M1
Choquet, S1
Garcilazo, Y1
Mokhtari, K2
Yang, N1
Tanner, JA1
Zheng, BJ1
Watt, RM1
He, ML1
Lu, LY1
Jiang, JQ1
Shum, KT1
Lin, YP1
Wong, KL1
Lin, MCM1
Kung, HF1
Sun, H1
Huang, JD1
Marinho, CC1
Nicolato, AJPG1
Reis, VW1
Dos Santos, RC1
Silva, JC1
Faria, HP1
Machado-Coelho, GLL1
Sun, Y2
Zhang, N1
Wang, J2
Guo, Y1
Sun, B1
Liu, W1
Zhou, H1
Yang, C1
Wei, L1
Ball, S1
Dennis, JA1
Bedanie, G1
Nugent, K1
Hayek, AJ1
Scott, V1
Yau, P1
Zolfaghari, K1
Goldwater, M1
Almquist, J1
Arroliga, AC1
Ghamande, S1
Wu, Q1
Ma, W1
Shi, R1
Zhang, B1
Mao, X1
Zheng, W1
Sbhatu, DB1
Berhe, GG1
Hndeya, AG1
Abraha, HB1
Abdu, A1
Gebru, HA1
Taye, MG1
Mulugeta, A1
Weldemichael, MY1
Tekle, HT1
Kidanemariam, HG1
Surger, M1
Angelov, A1
Liebl, W1
Hookey, L1
Bertiger, G1
Johnson, KL1
Boules, M1
Ando, M1
Dahdal, DN1
Riedl, JM1
Posch, F1
Prager, G1
Eisterer, W1
Oehler, L1
Sliwa, T1
Wilthoner, K1
Petzer, A1
Pichler, P1
Hubmann, E1
Winder, T1
Burgstaller, S1
Korger, M1
Andel, J1
Greil, R1
Neumann, HJ1
Pecherstorfer, M1
Philipp-Abbrederis, K1
Djanani, A1
Gruenberger, B1
Laengle, F1
Wöll, E1
Gerger, A1
Evans, WE1
Raynor, HA1
Howie, W1
Lipton, RB1
Thomas, GJ1
Wing, RR1
Pavlovic, J1
Farris, SG1
Bond, DS1
Hepprich, M1
Antwi, K1
Waser, B1
Reubi, JC1
Wild, D1
Christ, ER1
Braüner Christensen, J1
Aasbrenn, M1
Sandoval Castillo, L1
Ekmann, A1
Giver Jensen, T1
Pressel, E1
Haxholdt Lunn, T1
Suetta, C1
Palm, H1
Mansour, FA1
Al-Mazrou, A1
Al-Mohanna, F1
Al-Alwan, M1
Ghebeh, H1
Brown-Johnson, C1
Safaeinili, N1
Zionts, D1
Holdsworth, LM1
Shaw, JG1
Asch, SM1
Mahoney, M1
Winget, M1
Luo, Y1
Shan, H1
Gao, X1
Qi, P1
Li, Y2
Li, B1
Rong, X1
Shen, B1
Zhang, H1
Lin, F1
Tang, Z1
Fang, Z1
Peng, Z1
Jimenez, JL1
Ayer, GB1
Klepov, VV1
Pace, KA1
Zur Loye, HC1
Acquaroni, M1
Svartz, G1
Pérez Coll, C1
Otludil, B1
Ayaz, S1
Hill, A1
Elakkad, A1
Kuban, J1
Sabir, S1
Odisio, B1
Huang, SY1
Mahvash, A1
Miller, E1
Kroll, MH1
Overman, M1
Tam, AL1
Gupta, S1
Sheth, RA1
Deandreis, D1
Guarneri, A1
Ceci, F1
Lillaz, B1
Bartoncini, S1
Oderda, M1
Nicolotti, DG1
Pilati, E1
Passera, R1
Zitella, A1
Bellò, M1
Parise, R1
Carlevato, R1
Ricardi, U1
Gontero, P1
Coyne, GO'1
Wang, L2
Zlott, J1
Juwara, L1
Covey, JM1
Beumer, JH1
Cristea, MC1
Newman, EM1
Koehler, S1
Nieva, JJ1
Garcia, AA1
Gandara, DR1
Miller, B1
Khin, S1
Miller, SB1
Steinberg, SM1
Rubinstein, L1
Parchment, RE1
Kinders, RJ1
Piekarz, RL1
Kummar, S1
Chen, AP1
Doroshow, JH1
Chen, J2
Gan, L1
Tian, Y1
Shi, B1
Yang, Y1
Li, G1
Wu, D1
Wen, A1
Wu, Y1
Zhou, X1
Koyappayil, A1
Chavan, SG1
Mohammadniaei, M1
Go, A1
Hwang, SY1
Lee, MH1
Kurokawa, Y1
Yamashita, K1
Kawabata, R1
Fujita, J1
Imamura, H1
Takeno, A1
Takahashi, T1
Yamasaki, M1
Eguchi, H1
Doki, Y1
Schulte, T1
Sala, BM1
Nilvebrant, J1
Nygren, PÅ1
Achour, A1
Shernyukov, A1
Agback, T1
Agback, P1
Karami, H1
Shariatifar, N1
Nazmara, S1
Moazzen, M1
Mahmoodi, B1
Mousavi Khaneghah, A1
Sinha, N1
Mukhopadhyay, S1
Sau, M1
Qi, Y1
Wan, M1
Abd El-Aty, AM1
Li, H2
Cao, L1
She, Y1
Shao, Y1
Jin, F1
Wang, S1
Melendez-Araújo, MS1
Lemos, KGE1
Arruda, SLM1
Dutra, ES1
de Carvalho, KMB1
de la Plaza Llamas, R1
Díaz Candelas, DA1
Ramia, JM1
Zhu, S1
Liu, Z1
Lu, J2
Xiang, Z1
Lan, J1
Liu, J1
Yu, M1
Chen, Y2
Sirajudeen, AAO1
Annuar, MSM1
Subramaniam, R1
Somme, F1
Montaz-Rosset, MS1
Averous, G1
Deur, J1
Goichot, B1
Bachellier, P1
Addeo, P1
Imperiale, A2
Xu, L1
Li, Z2
Song, S1
Chen, Q1
Mo, L1
Wang, C2
Fan, W1
Yan, Y1
Tong, X1
Yan, H1
Singh, A1
Chen, HC1
Chen, YF1
Lu, YJ1
Wong, KT1
Chu, CW1
Banijamali, AR1
Carvalho, AE1
Wakefield, JD1
Germano, P1
Barden, TC1
Tobin, JV1
Zimmer, DP1
Masferrer, JL1
Profy, AT1
Currie, MG1
Todd Milne, G1
Zhang, Y1
Yang, H1
Dang, Z1
Zhan, S1
Sun, C1
Hu, G1
Lin, Y1
Yuan, Q1
Karayağiz Muslu, G1
Özdemir, M1
Del Prete, S1
Nocentini, A1
Supuran, CT1
Capasso, C1
Chagas, ATA1
Ludwig, S1
Pimentel, JDSM1
de Abreu, NL1
Nunez-Rodriguez, DL1
Leal, HG1
Kalapothakis, E1
Zhang, J1
Lin, L1
Dodig, D1
Kovačić, S1
Matana Kaštelan, Z1
Žuža, I1
Benić, F1
Slaven, J1
Miletić, D1
Rumboldt, Z1
Fernandez-Botran, R1
Wellmann, IA1
Une, C1
Méndez-Chacón, E1
Hernández de Rodas, E1
Bhandari, B1
Villagrán de Tercero, CI1
Nguyen, HTT1
Romano, F1
Wampfler, R1
Mühlethaler, K1
Tannich, E1
Oberli, A1
Yang, J1
Xiang, T1
Dai, L1
Zhao, X1
Ma, L1
Zuo, D1
Wei, B1
Sui, Y1
Xu, F1
Zheng, H1
Qiu, C1
Jin, H1
Kerwin, J1
Khan, I1
Rajasekhar, B1
Venkateshwaran, U1
Durairaj, N1
Divyapriya, G1
Nambi, IM1
Joseph, A1
Aliste, M1
Garrido, I1
Flores, P1
Hellín, P1
Vela, N1
Navarro, S1
Fenoll, J1
Castello, A1
Girard, A1
Galldiks, N2
Albert, NL1
Lopci, E2
Tatekawa, H2
Yao, J2
Oughourlian, TC2
Hagiwara, A2
Raymond, C2
Lai, A4
Cloughesy, TF5
Nghiemphu, PL3
Liau, LM3
Salamon, N2
Ellingson, BM4
Louarn, N1
Kauv, P1
Capelle, L2
Itti, E1
Uetani, H1
Ueda, I1
Bahri, S1
Pope, WB3
Jena, A1
Taneja, S1
Khan, AA1
Sogani, SK1
Dadone-Montaudié, B1
Ambrosetti, D1
Dufour, M1
Coyne, J1
Virolle, T1
Humbert, O1
Burel-Vandenbos, F1
Carideo, L3
Minniti, G6
Mamede, M1
Scaringi, C5
Russo, I1
Scopinaro, F4
Cicone, F5
Lowe, VJ3
Morris, JM2
Kemp, BJ2
Giannini, C3
Parney, IF3
Arcella, A1
Giangaspero, F1
Evangelista, L1
Cuppari, L1
Bellu, L1
Bertin, D1
Caccese, M1
Reccia, P1
Zagonel, V1
Lombardi, G1
Grams, MP1
Hoover, JM1
Hu, LS1
Sarkaria, JN2
Karunanithi, S4
Sharma, P4
Kumar, A4
Khangembam, BC3
Bandopadhyaya, GP3
Kumar, R4
Gupta, DK4
Malhotra, A3
Bal, C4
Singla, S1
Goenka, A1
Kosztyla, R1
Chan, EK1
Hsu, F1
Wilson, D1
Ma, R1
Cheung, A1
Zhang, S1
Moiseenko, V1
Benard, F1
Nichol, A1
Ballal, S1
Wardak, M1
Schiepers, C2
Dahlbom, M1
Phelps, ME3
Huang, SC1
Schwarzenberg, J1
Czernin, J5
Grogan, T1
Elashoff, D1
Geist, C1
Silverman, DH3
Chen, W5
Lapa, C1
Linsenmann, T1
Monoranu, CM1
Samnick, S1
Buck, AK1
Bluemel, C1
Kessler, AF1
Homola, GA1
Ernestus, RI1
Löhr, M1
Herrmann, K1
Karavaeva, E1
Harris, RJ1
Leu, K1
Shabihkhani, M1
Yong, WH1
Filss, CP1
Rossi-Espagnet, C1
Papa, A1
Bozzao, A2
Shah, NJ1
Nobili, F1
Bell, C1
Dowson, N1
Puttick, S1
Gal, Y1
Thomas, P1
Fay, M1
Smith, J1
Rose, S1
Janvier, L1
Olivier, P1
Morel, O1
Vignaud, JM1
Karcher, G1
Villani, V1
Carapella, CM1
Chiaravalloti, A1
Terrenato, I1
Piludu, F1
Vidiri, A1
Schillaci, O2
Floris, R1
Marzi, S1
Fabi, A1
Pace, A1
Nozza, P1
Cama, A1
Raso, A1
Mascelli, S1
Cabria, M1
Naseri, M1
Severino, M1
Tortora, D1
Rossi Espagnet, MC1
Romano, A1
Mancuso, V1
Napolitano, A1
Heimburger, C1
Chenard, MP1
Kremer, S1
Metellus, P1
Sala, Q1
Colin, C1
Bialecki, E1
Taieb, D1
Chinot, O1
Figarella-Branger, D1
Ledezma, CJ1
Sai, V1
Freitas, B1
Cloughesy, T2
Pope, W1
Alheit, H1
Oehme, L1
Winkler, C1
Füchtner, F1
Hoepping, A1
Grabowski, J1
Kotzerke, J1
Beuthien-Baumann, B1
Tripathi, M1
Sharma, R1
D'Souza, M1
Jaimini, A1
Panwar, P1
Varshney, R1
Datta, A1
Kumar, N1
Garg, G1
Singh, D1
Grover, RK1
Mishra, AK1
Mondal, A1
Fueger, BJ1
Geist, CL1
Walter, MA1
Nghiemphu, P1
Calabria, F1
Kitange, GJ1
Peterson, TE1
Ramiscal, JA1
Pokorny, JL1
De Sanctis, V1
Lanzetta, G1
Falco, T1
Di Stefano, D1
Esposito, V1
Enrici, RM1
Nioche, C1
Gontier, E1
Lahutte, M1
Dutertre, G1
Dulou, R1
Guillevin, R1
Foehrenbach, H1
Buvat, I1
Krasikova, RN1
Zaitsev, VV1
Ametamey, SM1
Kuznetsova, OF1
Fedorova, OS1
Mosevich, IK1
Belokon, YN1
Vyskocil, S1
Shatik, SV1
Nader, M1
Schubiger, PA1
Talbot, JN1
Kerrou, K1
Gault, N1
Gutman, F1
Grahek, D1
Touboul, E1
Schlienger, M1
Montravers, F1
Seibyl, JP1
Heiss, WD1
Wienhard, K1
Wagner, R1
Lanfermann, H1
Thiel, A1
Herholz, K1
Pietrzyk, U1
Uchida, K1
Takamatsu, K1
Kaneda, N1
Toya, S1
Tsukada, Y1
Kurosawa, Y1
Fujita, K1
Nagatsu, T1
Kohsaka, S1
Bräutigam, M1
Kittner, B1
Herken, H1
De Bault, LE1
Millard, SA1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)[NCT05553041]Early Phase 130 participants (Anticipated)Interventional2023-08-07Recruiting
Evaluation of 18F-Fluciclovine PET-MRI as a Biomarker of Response in Pediatric and Young Adult Patients With Low Grade Gliomas (LGG)[NCT05555550]Early Phase 130 participants (Anticipated)Interventional2024-01-31Not yet recruiting
A Phase II Study of Hypofractionated Stereotactic Radiotherapy Combined With Anlotinib in Patients With Recurrent High-Grade Glioma[NCT04197492]Phase 232 participants (Anticipated)Interventional2019-12-16Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for dihydroxyphenylalanine and Glioma

ArticleYear
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
    Current radiopharmaceuticals, 2019, Volume: 12, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emissi

2019
Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:10

    Topics: Dihydroxyphenylalanine; Feasibility Studies; Glioma; Humans; Neoplasm Grading; Positron-Emission Tom

2015
[PET and malignant cerebral tumors].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Pt 2

    Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma

2006
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
    Seminars in nuclear medicine, 2007, Volume: 37, Issue:6

    Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluo

2007

Trials

6 trials available for dihydroxyphenylalanine and Glioma

ArticleYear
Initial results of a phase II trial of
    Journal of neuro-oncology, 2022, Volume: 158, Issue:3

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm

2022
    Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34

    Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aer

2007
[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.
    PloS one, 2017, Volume: 12, Issue:9

    Topics: Adult; Aged; Amino Acid Transport Systems, Basic; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Fe

2017
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Journal of neuro-oncology, 2018, Volume: 137, Issue:3

    Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; H

2018
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:7

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; G

2013
Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:2

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Multimodal Imaging; Organotec

2014

Other Studies

48 other studies available for dihydroxyphenylalanine and Glioma

ArticleYear
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:5

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emissi

2022
Hybrid [
    Clinical neuroradiology, 2022, Volume: 32, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imagi

2022
Reply:
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:5

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Positron-Emission Tomography

2022
Role of Dynamic Parameters of 18F-DOPA PET/CT in Pediatric Gliomas.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Brain Neoplasms; Child; Dihydroxyphenylalanine; Glioma; Humans; Positron Emission Tomography Compute

2022
Manganese Dioxide-Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief.
    Small methods, 2022, Volume: 6, Issue:7

    Topics: Animals; Dihydroxyphenylalanine; Glioma; Hypoxia; Manganese Compounds; Oxides; Paclitaxel; Rats; Tum

2022
Added value of [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:9

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emissi

2023
Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
    Neuro-Chirurgie, 2019, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Contrast Media; Dihydrox

2019
Is IDH mutation status associated with
    Annals of nuclear medicine, 2020, Volume: 34, Issue:3

    Topics: Dihydroxyphenylalanine; Glioma; Humans; Mutation; Positron-Emission Tomography

2020
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:4

    Topics: Aged; Amyloidosis; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Glioma;

2020
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
    Clinical nuclear medicine, 2021, Volume: 46, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Methionine; Midd

2021
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:12

    Topics: Adult; Biological Transport; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenyla

2020
Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
    Clinical nuclear medicine, 2021, Jul-01, Volume: 46, Issue:7

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Male; Mu

2021
Preferential tumor localization in relation to
    Journal of neuro-oncology, 2021, Volume: 152, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Isocitrate Dehydrogenase; Neoplasm Grading;

2021
Recurrent Glioma: Does Qualitative Simultaneous 18F-DOPA PET/mp-MRI Improve Diagnostic Workup? An Initial Experience.
    Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Multiparametric

2021
    The British journal of radiology, 2018, Volume: 91, Issue:1084

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Female; Gli

2018
    Annals of nuclear medicine, 2019, Volume: 33, Issue:4

    Topics: Biological Transport; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes,

2019
The mean striatal
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:5

    Topics: Amino Acids; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomog

2019
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Neuro-oncology, 2013, Volume: 15, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Imm

2013
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    European radiology, 2013, Volume: 23, Issue:9

    Topics: Adult; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Proces

2013
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    International journal of radiation oncology, biology, physics, 2013, Dec-01, Volume: 87, Issue:5

    Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine

2013
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
    European journal of radiology, 2014, Volume: 83, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Ma

2014
¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasm

2014
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-01, Volume: 20, Issue:13

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Anti

2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydrox

2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
    Molecular imaging and biology, 2015, Volume: 17, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Contrast Media; Diffusion; Dihydroxyphenylalanine;

2015
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Glioma;

2015
Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity?
    Clinical nuclear medicine, 2015, Volume: 40, Issue:9

    Topics: Adolescent; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Neuronal Plasticity; Puta

2015
Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Pos

2015
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
    Anticancer research, 2015, Volume: 35, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Demography; Dihydroxyphenylalanine; Disease Progression; Female; Fluor

2015
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Neuro-oncology, 2015, Volume: 17, Issue:12

    Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18;

2015
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Neuro-oncology, 2015, Volume: 17, Issue:12

    Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18;

2015
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Neuro-oncology, 2015, Volume: 17, Issue:12

    Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18;

2015
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
    Neuro-oncology, 2015, Volume: 17, Issue:12

    Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18;

2015
18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:7

    Topics: Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Magne

2016
Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; False Negative Reactio

2016
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    The British journal of radiology, 2016, Volume: 89, Issue:1066

    Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female;

2016
FDOPA PET-CT of Nonenhancing Brain Tumors.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:4

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging;

2017
IDH mutation is paradoxically associated with higher
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8

    Topics: Adult; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocit

2017
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    European journal of radiology, 2009, Volume: 71, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Mag

2009
Radiation treatment planning in brain tumours: potential impact of 3-O-methyl-6-[(18)F]fluoro-L-DOPA and PET.
    Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:5

    Topics: Biopsy; Brain Neoplasms; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Glioma; Humans; Mag

2008
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalan

2009
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:10

    Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Middle Aged; Neoplasm Re

2010
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:9

    Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle

2012
The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
    Journal of neuro-oncology, 2013, Volume: 111, Issue:1

    Topics: Animals; Biological Transport; Blotting, Western; Brain Neoplasms; Dihydroxyphenylalanine; Fluoresce

2013
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
    Journal of neuro-oncology, 2013, Volume: 111, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine

2013
Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET/CT.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Ima

2013
Catalytic enantioselective synthesis of 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:5

    Topics: 2-Naphthylamine; Animals; Catalysis; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Isomeri

2004
F-Dopa as an amino acid tracer to detect brain tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:7

    Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluoro

1996
Synthesis of L-3,4-dihydroxyphenylalanine by tyrosine hydroxylase cDNA-transfected C6 cells: application for intracerebral grafting.
    Journal of neurochemistry, 1989, Volume: 53, Issue:3

    Topics: Animals; Brain; Dihydroxyphenylalanine; DNA; Female; Genetic Vectors; Glioma; Humans; Immunoblotting

1989
Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:1A

    Topics: Animals; Biopterins; Catechols; Cell Line; Clone Cells; Dihydroxyphenylalanine; Dopamine; Glioma; Mi

1985
Inhibition of growth by 6-hydroxydopamine in cultured cells of neuronal and nonneuronal origin.
    Cancer research, 1973, Volume: 33, Issue:4

    Topics: Alcohol Oxidoreductases; Animals; Astrocytoma; Carbon Isotopes; Cell Division; Cell Line; Cell Membr

1973